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Abstract
Outline
In chronic lung infections by Pseudomonas aeruginosa (PA) the bacteria thrive in biofilm
structures protected from the immune system of the host and from antibiotic treatment.
Increasing evidence suggests that the susceptibility of the bacteria to antibiotic treatment
can be significantly enhanced by hyperbaric oxygen treatment. The aim of this study is to
simulate the effect of ciprofloxacin treatment in a PAO1 biofilm model with aggregates in
agarose when combined with hyperbaric oxygen treatment. This is achieved in a reaction-
diffusion model that describes the combined effect of ciprofloxacin diffusion, oxygen diffu-
sion and depletion, bacterial growth and killing, and adaptation of the bacteria to ciprofloxa-
cin. In the model, the oxygen diffusion and depletion use a set of parameters derived from
experimental results presented in this work. The part of the model describing ciprofloxacin
killing uses parameter values from the literature in combination with our estimates (Jacobs,
et al., 2016; Grillon, et al., 2016). Micro-respirometry experiments were conducted to deter-
mine the oxygen consumption in the P. aeruginosa strain PAO1. The parameters were vali-
dated against existing data from an HBOT experiment by Kolpen et al. (2017). The
complete oxygen model comprises a reaction-diffusion equation describing the oxygen con-
sumption by using a Michaelis-Menten reaction term. The oxygen model performed well in
predicting oxygen concentrations in both time and depth into the biofilm. At 2.8 bar pure oxy-
gen pressure, HBOT increases the penetration depth of oxygen into the biofilm almost by a
of factor 4 in agreement with the scaling that follows from the stationary balance between
the consumption term and diffusion term.
Conclusion
In the full reaction-diffusion model we see that hyperbaric oxygen treatment significantly
increases the killing by ciprofloxacin in a PAO1 biofilm in alignment with the experimental
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results from Kolpen et al. (Kolpen, et al., 2017; Kolpen, et al. 2016). The enhanced killing, in
turn, lowers the oxygen consumption in the outer layers of the biofilm, and leads to even
deeper penetration of oxygen into the biofilm.
Introduction
Pseudomonas aeruginosa is a gram-negative bacterium associated with the lung disease cystic
fibrosis (CF) [5]. CF is an autosomal recessive disease caused by a defect in the cystic fibrosis
transmembrane conductance regulator gene (CFTR) [6]. CFTR is a chloride ion channel that
reduces the mucus volume of the epithelial lining fluid leading to dehydration and mucociliary
dysfunction [7, 8]. The stagnation of mucus contributes to accumulation of bacteria, including
Pseudomonas aeruginosa. Consequently, a sustained inflammatory response results in a grad-
ual decline in lung function ultimately causing death for CF patients [9, 10].
Microscopical examinations indicate that P. aeruginosa resides in microcolonies, also
known as biofilms, surrounded by numerous polymorphonuclear leukocytes (PMN) in the
endobronchial mucus in lungs from CF patients with chronic lung infection [11]. In vivo mea-
surements have revealed intense depletion of oxygen (O2) in the endobronchial mucus in CF
patients with chronic lung infection [12]. The extreme depletion of O2 is reproduced in newly
expectorated endobronchial secretions as steep oxyclines [13, 14] and is predominately caused
by O2 consumption for production of reactive O2 and nitrogen species by the PMNs [15–17].
Consequently, O2 consumption by aerobic respiration is very small and anaerobic bacterial
respiration is favoured in the O2 depleted parts of endobronchial secretions from CF patients
[13, 18]. The ability of the O2 consumption by the accumulated PMNs to restrict P. aeruginosa
is further evidenced by the inhibition of aerobic growth of P. aeruginosa by the PMNs in the
endobronchial mucus in CF lungs [19].
Studies suggest that O2 limitation in the adhered biofilm resulting in low metabolic activity
is correlated with high survival rates of P. aeruginosa’s during antibiotic treatment [20]. The
biofilms in CF lungs are, however, not adhered to solid surfaces, but are embedded as small
aggregates in the viscous endobronchial mucus [21]. To mimic the organisation of P. aerugi-
nosa in small aggregates surrounded by viscous mucus we have embedded P. aeruginosa in
agarose allowing us to confirm that the killing of P. aeruginosa biofilm by ciprofloxacin is oxy-
gen dependent and to demonstrate that hyperbaric oxygen treatment (HBOT) increases the
killing of P. aeruginosa by ciprofloxacin [4]. To further approach the situation in the infected
CF lungs we mimicked the PMN-mediated low availability of oxygen for aerobic bacterial res-
piration by culturing the biofilms embedded in agarose for three days before assessing the
effect of HBOT on the killing of P. aeruginosa during treatment with ciprofloxacin [3]. In this
way we could demonstrate that when aerobic respiration was enabled by reoxygenation during
HBOT, P. aeruginosa became susceptible to ciprofloxacin, thus confirming the contribution of
bacterial respiration to increased bacterial killing by antibiotics [22]. P. aeruginosa is known to
have five terminal oxidases in the electron transport chain which directly consume oxygen by
reduction [23]. Although less efficient, P. aeruginosa is also capable of anaerobic respiration
with N-oxides as terminal electron acceptors, leaving its overall metabolism complex [24, 25].
CF patients are treated with a wide range of antibiotics [26, 27]. The killing effect of some
antibiotics, e. g. fluoroquinolones, aminoglycosides, and beta-lactams is enhanced under aero-
bic conditions due to formation of reactive oxygen species (ROS) [4, 28], hence oxygen avail-
ability and aerobic respiration are relevant for treatment. Two antibiotics used to treat P.
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
PLOS ONE | https://doi.org/10.1371/journal.pone.0198909 June 14, 2018 2 / 16
Number: HOIBY05A0 | Recipient: Niels Høiby. The
funders played no role in experimental design, data
analysis and interpretation, nor the decision to
submit the work for publication.
Competing interests: The authors have declared
that no competing interests exist.
aeruginosa biofilm infections in CF are tobramycin and ciprofloxacin [26]. Tobramycin has
shown a considerable time delay for the penetration into biofilms which probably increases
the adaptive response in the bacteria [29]. Several simulation studies of the bacterial killing of
P. aeruginosa with and without adaptation have been carried out with various antibiotics,
including ciprofloxacin, illuminating their pharmacokinetic and dynamic properties on P. aer-
uginosa infection and how time kill-curves evolve during treatment [30–32]. However, none
have yet linked the observed increased killing from HBOT to an antibiotic adaptation model.
This paper investigates the dynamics of O2 treatment and the resulting O2 concentration
profiles in a biofilm model of P. aeruginosa. The model parameters are determined in respi-
rometry experiments and from the O2 penetration and unloading dynamics reported by Kol-
pen et al. [3] and shown in Fig 1. Using the oxygen model in combination with a modified
version of an existing antibiotic model with ciprofloxacin treatment by Jacobs et al. (2016) [1]
and Gregoire et al. (2010) [30], the dynamics of bacterial killing in a biofilm is investigated and
the limitations of this and existing models are discussed.
Fig 1. Oxygen profiles sampled after 90 minutes of HBOT. Oxygen profiles are recorded after 90 minutes of HBOT applied to a 5 mm
thick agarose biofilm, hence an unloading process of an already oxygen penetrated biofilm is observed. Oxygen profiling was initiated 4
minutes after the 90 minutes HBOT and every profile takes approximately 3 minutes to record. Horizontal black bars represent supernatant
and biofilm surfaces, respectively. The concentration of oxygen in the supernatant immediately after treatment is approximately 1000 μM as
the chamber has to be decompressed to 1 atm. The biofilm is present for depth 0 mm to 5 mm while the supernatant is present in the region
from −5 mm to 0 mm. The supernatant is displayed primarily to verify that the mixing is strong in this region. Figure modified from [3].
https://doi.org/10.1371/journal.pone.0198909.g001
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Materials and methods
Bacterial strain and growth media
The standard laboratory P. aeruginosa strain PAO1 was obtained from Stover et al. [33].
Growth was established in Lysogeny broth (LB) [5 g/L yeast extract (Oxoid, Basingstoke, UK),
10 g/L tryptone (Oxoid) and 10g/L NaCl (Merck, Rahway, NJ), pH 7.5], incubated overnight
at 37˚C and shaken at 150 rpm. Overnight cultures were used in micro-respirometry experi-
ments to estimate O2 consumption in stationary cultures. For O2 consumption experiments in
exponential cultures, the overnight culture was diluted in LB to OD600 = 0.01 and grown until
OD600 = 0.4. Bacterial CFU counts were determined on solid lactose agar plates (‘Blue plates’
based on a modified Conradi–Drigalski medium containing 10 g/L detergent, 1 g/L Na2S2O3 
H2O, 0.1 g/L bromothymolblue, 9 g/L lactose and 0.4 g/L glucose, pH 8.0; Statens Serum Insti-
tut, Copenhagen, Denmark) to select for Gram-negative bacteria. All plates were incubated
overnight at 37˚C.
Oxygen depletion measurements
For bulk O2 depletion experiments in planktonic cultures respiration vials (OXVIAL4) with
integrated stripes of the O2 sensitive REDFLASH-indicators glued to the inner wall (Pyro-Sci-
ence, GmbH) were positioned on top of a magnetic stirring head connected to a magnetic stir-
rer (Model 300, Rank Brothers, Cambridge, UK). The O2 concentration measurements were
recorded with separately available adaptor rings (ADVIAL4, Pyro-Science) to allow easy fixa-
tion of bare optical fibers (SPFIB-BARE, Pyro-Science) which connect the respiration vials to
an optical oxygen meter (FireStingO2, FSO2-4, Pyro Science). The software Pure Oxygen Log-
ger (v.3.206 with FireStingO2 (Firmware 3.07), Pyro-Science) measured O2 in continuous
mode with sampling every 1 s. The used channels were activated; the respective sensor code,
output unit, as well as environmental conditions for the sample temperature ([˚C]), pressure
([mbar]), and salinity ([g/L]) were entered. The temperature was fixed at 37˚C and the pres-
sure was fixed at 1013 mbar. The factory calibration was used to calibrate the sensors
(OXVIAL4) according to the manufacturer’s recommendation. O2 concentrations were mea-
sured in both stationary and exponential cultures diluted 10 times in LB.
For vertical space-time profiles in biofilms we used the data reported by Kolpen et al. [3].
For completeness, we provide brief experimental details for these data: PAO1 biofilms were
grown and treated under anoxic conditions in an anaerobic growth chamber. The optical den-
sity at 600 nm (OD600) of overnight cultures of PAO1 was adjusted to 0.4 before 100-fold dilu-
tion in LB medium supplemented with 2% 2-hydroxyethyl-agarose (Sigma-Aldrich, Brøndby,
Denmark) and 1 mL was loaded into 24-well microtiter plates to achieve a cell loading of
*106 cells/ml. The biofilm size was 5.7 mm high and 15 mm wide. The medium was supple-
mented with anoxic NaNO3 (1 mM) to enable anaerobic respiration. The supernatant was
replaced daily with 1 mL of LB medium supplemented with 1 mM NaNO3. Microtiter plates
were covered with Parafilm and lid and were incubated under anoxic conditions at 37˚C for 3
days. The 3 day old biofilm was treated for 90 min with HBOT (100% O2 at 2.8 bar). Less than
1 minute after ending the treatment, the microtiter plate was positioned on a heated metal
rack and kept at 37˚C. The vertical O2 profiles were recorded with a fiber-optic O2 microsen-
sor positioned with a micromanipulator (50 μm tip diameter, FireSting2, Profix version 4.51;
Pyro-Science GmbH, Germany). The microsensor was calibrated according to the manufac-
turer’s recommendations (air saturated and O2-free water). The microsensor was positioned at
the base of the biofilm sample and profiles were recorded while moving the sensor in vertical
steps of 100 μm through the biofilm sample.
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Analysis
Overview of Analysis: First we model the oxygen consumption in a well mixed culture as
described in “Reaction model”. This serves to determine the basic parameters needed to
describe the oxygen consumption. Next, in “Reaction-diffusion model for oxygen”, we com-
bine the obtained oxygen consumption model with a simple diffusion model. This allows us to
verify that the hyperbaric oxygen penetration into a biofilm model reported by [3] and shown
in Fig 1 are qualitatively described. Finally, in “Ciprofloxacin model with oxygen consump-
tion”, a full model describing the killing by ciprofloxacin in combination with hyperbaric oxy-
gen treatment is constructed. This model includes a mechanism for reversible adaptive
oxygen-dependent killing. This enables us to give predictions for the combined effect of
HBOT and ciprofloxacin treatment.
Reaction model
A simple reaction model using a Michaelis-Menten reaction term is presented in Eq (1) where
c is the molar concentration of oxygen. The model includes two parameters, namely Km and
Rmax. The latter is the maximum consumption rate and has in other studies [34–37] been
decomposed into a subset of parameters as seen in Eq (2), where μmax is the maximum specific
growth rate with units of h−1, εc is the dimensionless volume fraction occupied by cells, ρx is
the intrinsic cellular oxidase density with units μM, and Yx,o is the dimensionless oxygen yield
coefficient. Importantly, Eq (1) reveals that the overall consumption in a biofilm scales linearly
in the volume fraction occupied by cells.
dc
dt
¼   Rmax
c
Km þ c
ð1Þ
Rmax ¼
mmax εc rx
Yx;o
ð2Þ
The parameter Km acts as a cut-off value, indicating the oxygen concentration below which
limitation sets in. Even though PA has five terminal oxidases which reduce oxygen [24], we
shall describe the process using just one value for Km. This works well, since the individual cut-
offs all lie within an order of magnitude from Km = 4 μM [23]. Our maximal oxygen reaction
velocity therefore represents the sum of contributions from all oxidases.
The solution to Eq (1) is obtained by integration as presented in Eq (3) where c(0) is the ini-
tial concentration of oxygen.
cðtÞ ¼ Km W
cð0Þ
Km
exp
cð0Þ   Rmax t
Km
  
ð3Þ
The solution involves the Lambert W function, which is the inverse of x! xex [38]. Estimates
of Rmax and Km may now be established by fitting the experimental data as illustrated in Fig 2.
Experimental data is obtained from respirometry experiments as described in Materials and
Methods.
In Fig 2, three typical respirometry profiles and fits with Eq (3) are shown. Using the solu-
tion from Eq (3), the value of Km was determined from a total of 14 respirometry experiments
shown in S1–S4 Figs. The parameter values providing the best fit were computed using the
Levenberg-Marquardt algorithm in MATLAB with an integer weighting to compensate for the
statistical underrepresentation of data in the tail.
The average Km for the first batch of experiments with six similar cultures is 3.4 μM (see S1
and S2 Figs). In Fig 2, three of these are shown. Additionally, another batch of eight
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
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respirometry experiments were conducted where an average Km of 0.62 μM was observed (see
S3 and S4 Figs). Clearly, Km is very low and the bacteria can thus easily be saturated with oxy-
gen. The variation in Km probably arises from the interactivity of the five terminal oxidases
present in P. aeruginosa [39]. A study by Arai et al. [23] determined Km for each oxidase to be
between 0.23-4.3 μM corresponding well to the respirometry results.
The estimate of Rmax in Fig 2 is centered around 1.5 attomol per second per bacteria but
some variation of this parameter was seen across the 14 different profiles. The mean value of
Rmax was calculated to be 2:57 amolsbac and ranges from a minimum value of 1:22
amol
sbac to a maxi-
mum value of 5:70 amolsbac. Interestingly, it was observed that the cultures that exhibited exponen-
tial growth had an average Rmax value of 4:48 amolsbac which would indicate a shift in consumption
rate per bacteria when entering a stationary phase. However, the number of profiles of expo-
nentially growing cultures was low (n = 3) and further respirometry experiments are therefore
required to confirm this.
Reaction-diffusion model for oxygen
As a first attempt to understand the effect of HBOT in biofilm, oxygen profiles were sampled
immediately after HBOT by Kolpen et al. (2017) in [3] as reproduced in Fig 1. In the experi-
ment, a series of oxygen profiles were sampled after 90 minutes of HBOT as the oxygen level
returned to normoxic. By modelling the oxygen profiles one should be able to predict the con-
dition of the biofilm during treatment. Assuming that the underlying oxygen consumption
mechanism is similar to that in the planktonic cells in the respirometry experiments, the data
can be described by adding a diffusion term to the rhs of Eq (1). We then get a 1-dimensional
reaction-diffusion equation as seen in Eq (4).
@c
@t
¼ DO2
@
2c
@z2
  Rmax
c
Km þ c
ð4Þ
When the concentration of oxygen is large, c Km, the penetration depth of oxygen scales
in proportion to the square root of the oxygen concentration at the boundary.
Fig 2. Oxygen consumption for overnight cultures of PAO1. Dots represent experimental data and the red lines are the solution from Eq (3) with respective
parameters.
https://doi.org/10.1371/journal.pone.0198909.g002
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
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When the oxygen concentration is below Km, the reaction-diffusion equation is reduced to:
@c
@t
¼ DO2
@
2c
@z2
 
Rmax
Km
c ð5Þ
with the steady state solution
cðzÞ ¼ c0 e  λzz ð6Þ
for thick biofilms.
The first-order assumption gives the relationships between Km and Rmax:
Rmax ¼ KmDO2λ
2
z λt ¼ DO2λ
2
z ð7Þ
These relationships make it possible to estimate Rmax. Although estimates of this parameter
were already made in the previous analysis of the respirometry experiments, it would be
appropriate to compare the maximum consumption in a biofilm culture with the planktonic
cultures used in the respirometry experiments. The fit was made on the tail of the last oxygen
profile in Fig 1 such that a steady-state approximation was appropriate, and for data points
below 4 μM such that a first-order reaction could be assumed. The fit was done with the Leven-
berg-Marquardt method in MATLAB R2016b. The result of the interpolation and fit is shown
in S5 Fig. Prior to fitting the data were smoothed using cubic spline in interp1 in MATLAB
R2016b and an offset correction was included in the fit.
The resulting estimate of Rmax is 81 μM/min in the upper part of the biofilm. This value was
calculated by choosing a representative value for Km of 3.8 μM, the mean of the cutoffs
obtained by Arai et al. (2014) [23] of the bo3, CIO, and aa3 enzymes, which are the ones we
expect to dominate the oxygen consumption during HBOT [23]. As noted, the oxidase regula-
tion of the five oxidases is quite complex [39] and may influence the value of Km.
In the experiment reported by Kolpen et al. [3], where the supernatant is replaced and con-
tains fresh nutrient as well as NaNO3 during the anaerobic phase, the cell density is higher in
the top of the biofilm after the three days of anaerobic growth. We may estimate the cell den-
sity from the fitted reaction velocity, Rmax = 81 μM/min and the consumption per bacteria,
*3 amol/s/cell and arrive at 5  108 CFU/mL near the surface of the biofilm. This is signifi-
cantly higher than the average density in the biofilm in [3] which is in the order of 107 CFU/
mL. The elevated value is a consequence of unevenly distributed growth in the biofilm result-
ing from oxygen during aerobic growth and NaNO3 during anaerobic growth, both being sup-
plied from the biofilm interface. Bearing in mind the uneven cell distribution in the
experiment, we expect only a qualitative agreement between the model and the data.
The reaction-diffusion equation in Eq (4) was solved with the numerical solver pdepe in
MATLAB that uses an implementation by Skeel et al. [40]. Since the supernatant appears to be
only moderately mixed we adapted a pragmatic approach where the boundary concentrations
at the surface of the biofilm are controlled by a polynomial spline fitted to the experimental
data. Similarly the initial concentration of oxygen in the biofilm is constructed as a polynomial
spline through the first oxygen profile in Fig 1. The algorithm chosen to fit the parameters in
Eq (3) was the Levenberg-Marquardt algorithm in MATLAB.
Ciprofloxacin model with oxygen consumption
The reaction-diffusion model provides a suitable basis for investigating the effect of oxygen
when treating PAO1 biofilms with antibiotics. A generic model is presented here, containing
mechanisms that introduce oxygen-induced antibiotic killing.
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
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The geometry of such a model is seen in Fig 3 showing one domain for introduction of anti-
biotics, i.e. the supernatant and another for the biofilm [3]. The model is intended to provide a
qualitative prediction for an experiment in a microtiter plate filled with 5 mm biofilm contain-
ing agarose with 1.25 mm well mixed liquid supernatant. Ciprofloxacin and oxygen levels are
controlled in the supernatant from where it diffuses into the biofilm. Reflective boundary con-
ditions at the bottom are assumed for oxygen and ciprofloxacin.
Adaptation of bacteria to the antibiotic can be modelled in several ways. However, model 5
from Jacobs et al. (2016) [1] fits well in this context as it contains one bacterial population with
a reversible adaptation to antibiotics. In order to make the ciprofloxacin killing dependent on
the growth rate, we multiply the killing term by the normalised growth rate as seen in the last
term in Eq (10). The resulting model is displayed in Eqs (8)–(13), where z is the depth into the
biofilm.
Inside the biofilm, i. e. for z> 0, the model reads
Oxygen:
@c
@t
¼ DO2
@
2c
@z2
  Rmax
c
Km þ c
ε
εnorm
ð8Þ
Ciprofloxacin:
@u
@t
¼ Dcip
@
2u
@z2
ð9Þ
Bacteria:
@ε
@t
¼ mðcÞ 1  
ε
εmax
 
ε   Kmax
mðcÞ
mmax
ug
KC
g
50S þ ug
ε ð10Þ
Adaptation:
@b
@t
¼
Smax u
SC50 þ u
  b
 
kout ð11Þ
Fig 3. Geometry of ciprofloxacin model coupled with oxygen treatment. Sketch of the 1-dimensional model
implemented in MATLAB. The origin is placed at the interface between the supernatant and the biofilm domains,
hence the top of the supernatant has coordinate z = −1.25 mm, the top of the biofilm has z = 0 mm, and the bottom of
the biofilm has coordinate z = 5 mm.
https://doi.org/10.1371/journal.pone.0198909.g003
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Functions:
KC 50S ¼ KC 50;base ð1þ bÞ ð12Þ
mðcÞ ¼ mmax
c
Km þ c
ð13Þ
Eq (8) is the oxygen model from Eq (4) but the reaction term is scaled to be proportional to
the fraction of live bacteria in the biofilm. Eq (9) describes the diffusion of ciprofloxacin from
the supernatant into the biofilm. Eq (10) describes the change in bacterial concentration within
the biofilm and is separated into two terms describing the oxygen-dependent growth and the
oxygen-dependent killing effect of ciprofloxacin, respectively. The growth term in Eq (10) is
assumed to follow a local logistic growth model with an oxygen dependent specific growth rate
following Monod kinetics as shown in Eq (13). This is a fair assumption since the volume frac-
tion occupied by cells is well below 1% in the studied biofilms.
The initial bacterial concentration in the biofilm is set to 5  108 CFU/mL so the simulation
captures the estimated oxygen consumption in the top of the biofilm, as observed in the exper-
iments by Kolpen et al. [3, 4]. This is about an order of magnitude lower than in a fully devel-
oped biofilm. To ensure an oxygen-dependent killing, the killing term is scaled by the
normalised oxygen-dependent growth (μ(c)/μmax). A similar strategy for incorporating oxy-
gen-dependent killing was used by Stewart (1994) [34] in a model without adaptation. The
effect of an adaptive susceptibility to antibiotics has been shown to be considerable [30, 32].
Eq (11) includes both an up and down regulation of adaptation.
The combined oxygen and ciprofloxacin model in Eqs (8)–(13) was solved with pdepe
using a 1-dimensional model presented in Fig 3 assuming radial and axial symmetry. We use
the estimated oxygen consumption parameters, diffusion parameters, and kinetic parameter
values suggested in the literature as detailed in Table 1. Both oxygen and ciprofloxacin are
assumed to be well mixed in the supernatant domain and this was implemented in pdepe by
Table 1. Parameter values used for simulation of the oxygen and ciprofloxacin models.
Parameter Symbol Value Reference
Diffusion constant of oxygen DO2 9.44 mm
2/h [41]
Maximum oxygen reaction velocity Rmax 81 μM/min CSa,b
Oxygen concentration for half-maximum reaction velocity Km 3.8 μM [23], CS
Diffusion constant ciprofloxacin Dcip 1.44mm2/h [42]
Maximum effect of ciprofloxacin Kmax 8 h−1 [3], CSc
Maximum specific growth rate μmax 0.40 h−1 [37]
Maximum adaptation Smax 4 [1]
Initial half-maximum killing rate concentration of ciprofloxacin KC50,base 0.2 μg/mL [2]
Antibiotic concentration that yields 50% of Smax SC50 1.06 μg/mL [1]
Turnover rate constant for adaptation kout 0.05 h−1 [1]
Hill coefficient γ 1.2 [30]
Maximum population density εmax 10
9.5 CFU/mL [1]
Normalisation constant εnorm 5  10
8 CFU/mL CS
a Current Study
b Estimated from fit of λt and respirometry experiments.
c Estimated from time-kill curves by Kolpen and coworkers.
https://doi.org/10.1371/journal.pone.0198909.t001
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setting an artificially high diffusion constant, hence it remains nearly uniformly distributed in
the supernatant domain throughout the simulation. As an alternative to using a unit step func-
tion to connect the variables across the interface we use a fast shifting logistic function.
The initial conditions in the biofilm are c0 = 0, u0 = 0, ε0 = 106 CFU/mL, and β0 = 0, and the
initial conditions in the supernatant domain are c0 = the applied oxygen concentration, u0 =
the actual dose, ε0 = 0 CFU/mL, and β0 = 0. Hence, the introduction of antibiotics is imple-
mented as a uniform initial condition in the supernatant.
Results and discussion
Oxygen model
Using the estimated parameters for Rmax and Km, the reaction-diffusion equation, Eq (4), was
simulated and compared with the experimental oxygen profiles in Fig 1 as shown in Fig 4.
Looking at Fig 4, the dynamics of the oxygen profiles are qualitatively described by a reac-
tion-diffusion model with a Michaelis-Menten reaction term. As mentioned, Rmax is propor-
tional to the CFU unit count in the biofilm and is thus scaled linearly with the live cell-to-
volume fraction in Eq (2). A more detailed model could include a reaction velocity scaled to
per bacteria such that the units of Rmax would be in amols−1 bac−1. Such a model would be
able to describe oxygen consumption across a larger range of bacterial concentrations instead
of relying on an estimate of Rmax for a specific cell density as done here. In S1 and S2 Figs it is
observed that there is a difference between zero-growth and exponential-growth PAO1 cul-
tures. Generally, the larger Rmax values suggest that exponential-growth cultures are consum-
ing oxygen at a higher capacity per bacterium than zero-growth bacteria. However, further
Fig 4. Numerical solutions of the reaction-diffusion equation with a michaelis-menten reaction term. Dots are experimental data from Fig 1 and the
coloured lines are matching numerical solutions to Eq (4). The biofilm extends from depth 0 mm to 5 mm, but only the part with measurable oxygen
concentration is shown in the figure.
https://doi.org/10.1371/journal.pone.0198909.g004
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
PLOS ONE | https://doi.org/10.1371/journal.pone.0198909 June 14, 2018 10 / 16
studies are needed to accurately estimate at which bacterial concentration the shift from expo-
nential capacity to stationary capacity happens.
Also, Km may vary between different experiments depending on their growth conditions
prior to starting HBOT because of the five terminal oxidases that respond to different regula-
tory mechanisms as described by [39].
Antibiotic model
As mentioned, it has been thoroughly investigated by Kolpen et al. [3, 4] that treatment of P.
aeruginosa with fluoroquinolones like ciprofloxacin shows a time-dependent increased killing
when supplementing treatment with high concentrations of oxygen. We have proposed a phar-
macodynamic biofilm model accounting for this increased killing, as seen in Eqs (8)–(13).
The simulations show an oxygen-dependent increased killing as seen in Fig 5 where the vol-
ume averaged CFU counts are displayed. At the largest ciprofloxacin dose, we observe 2 orders
of magnitude decrease in the CFU after about 2 hours of combined ciprofloxacin and HBOT
treatment.
HBOT increases the penetration depth as seen in Fig 6. This leads to faster growth and met-
abolic activity, thus making the bacteria more susceptible to antibiotic treatment. However,
Fig 5. Predicted volume-averaged time kill curves for normoxic oxygen treatment and HBOT. Different dosing schemes over 4 hours of
treatment simulated in a 5 mm biofilm model. The initial ciprofloxacin concentrations in the 1.25 mm supernatant are displayed in the figures
while the fully equilibrated concentrations are 5 times lower. Left: Normoxic treatment. Right: Hyperbaric oxygen treatment.
https://doi.org/10.1371/journal.pone.0198909.g005
Fig 6. Oxygen penetration. Simulation of oxygen penetration in a 5 mm biofilm following a 4 hour treatment scheme with six different
ciprofloxacin dosings. The initial concentration ciprofloxacin in the supernatant is indicated in the figure. The equilibrated concentration is 5
times lower. Left: Normoxic treatment. Right: Hyperbaric oxygen treatment.
https://doi.org/10.1371/journal.pone.0198909.g006
HBOT enhanced ciprofloxacin killing in Pseudomonas aeruginosa biofilms
PLOS ONE | https://doi.org/10.1371/journal.pone.0198909 June 14, 2018 11 / 16
Fig 5 indicates that the opposing growth is still large enough to compensate the oxygen-depen-
dent killing for initial doses below 1 μg/mL (0.2 μg/mL equilibrated concentration). Fig 7
reveals the distribution of live bacteria in the biofilm: bacteria survive near the bottom and die
at the top.
The combined oxygen model with antibiotic killing provides a mechanism for oxygen
enhanced killing. The model has a number of opposing effects such as bacterial growth, oxy-
gen-dependent killing, antibiotic adaptation, and oxygen consumption that all contribute to
the killing of bacteria. The HBOT makes the culture metabolically active deep into the biofilm.
At sufficiently high concentrations of antibiotics the metabolic activity is suppressed and the
oxygen is allowed to penetrate even deeper into the biofilm. This, in turn, allows killing even
below the normal penetration depth for the oxygen. In this sense, the effect is self-perpetuat-
ing. Of course, the parameter values have a significant influence on the simulation and the
above dynamics. In further studies it would be interesting to challenge the model against
experimental data to see if our model that incorporates oxygen-dependent killing suffices in
describing the already observed increased bacterial killing under oxygen treatment by [3, 4].
Conclusion
A reaction-diffusion model with a Michaelis-Menten reaction term adequately describes P.
aeruginosa’s oxygen consumption in an artificial PAO1 biofilm. Important model parameters,
Km and Rmax, have been determined by performing respirometry experiments and fitting data
to an existing PAO1 experiment with HBOT, respectively. Furthermore, we constructed an
antibiotic model that included a mechanism for adaptive oxygen-dependent killing of P. aeru-
ginosa by introducing a normalised oxygen-growth rate into the antibiotic killing. The increase
of the penetration depth of oxygen caused by the HBOT is further boosted by the killing effect
from the antibiotics, thus causing the effect to be more efficient than would be naively
expected.
In the model, oxygen limitation allows P. aeruginosa to survive in biofilms in a dormant
state. Hyperbaric oxygen treatment induces metabolic activity and growth, thus increasing the
susceptibility for antibiotics leading to a more efficient killing of bacteria. In the specific geom-
etry studied, we find that 4 hours of combined treatment with HBOT and ciprofloxacin at
Fig 7. Bacterial killing along the depth dimension of the biofilm. Simulation of a 4 hour treatment scheme with six different doses of
ciprofloxacin in a 5 mm biofilm model. The initial concentration ciprofloxacin in the supernatant is indicated in the figure while the
equilibrated concentration is 5 times lower. Bacterial density is measured in (CFU/mL). Left: Normoxic treatment. Right: Hyperbaric oxygen
treatment.
https://doi.org/10.1371/journal.pone.0198909.g007
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initial concentration 1 μg/mL, results in an equilibrated ciprofloxacin concentration of 0.2 μg/
mL and full penetration of oxygen. This, in turn, ensures efficient killing.
The oxygen model presented here describes the oxygen consumption in PAO1 biofilms
qualitatively and it is clear that HBOT has the potential to play an important role in the treat-
ment of P. aeruginosa biofilm infections with selected antibiotics.
Supporting information
S1 Fig. Fit of the last oxygen profile from Fig 1. Interpolation (black dots) of last oxygen pro-
file (blue dots) from in vitro experiment with PAO1 biofilm after HBOT by Kolpen et al.
(2016) and subsequent fit of interpolated data (red line).
(EPS)
S2 Fig. Oxygen consumption for exponential PAO1 culture. Dots represent experimental
data and the red line is the fit. CFU from left to right: 2.2, 2.40, and 2.80  107 mL−1.
(EPS)
S3 Fig. Oxygen consumption for stationary PAO1 culture. Dots represent experimental data
and the red line is the fit. CFU is 1.8  109 mL−1 for all three.
(EPS)
S4 Fig. Oxygen consumption for stationary PAO1 culture. Dots represent experimental data
and the red line is the fit. CFU = 1.7  108 mL−1.
(EPS)
S5 Fig. Oxygen consumption for stationary PAO1 culture. Dots represent experimental data
and the red line is the fit. CFU = 2.3  108 mL−1.
(EPS)
S6 Fig. Concentration of ciprofloxacin in the supernatant and the biofilm 2, 4, 6, and 8
hours after introduction of 4 μg/mL in the supernatant.
(EPS)
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